ETON PHARMACEUTICALS INC (ETON) Fundamental Analysis & Valuation

NASDAQ:ETON • US29772L1089

Current stock price

26.36 USD
-0.74 (-2.73%)
At close:
26.37 USD
+0.01 (+0.04%)
After Hours:

This ETON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ETON Profitability Analysis

1.1 Basic Checks

  • ETON had negative earnings in the past year.
  • In the past year ETON had a positive cash flow from operations.
  • ETON had negative earnings in each of the past 5 years.
  • Of the past 5 years ETON 4 years had a positive operating cash flow.
ETON Yearly Net Income VS EBIT VS OCF VS FCFETON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • ETON has a Return On Assets of -4.99%. This is in the better half of the industry: ETON outperforms 72.40% of its industry peers.
  • With a decent Return On Equity value of -17.59%, ETON is doing good in the industry, outperforming 69.79% of the companies in the same industry.
Industry RankSector Rank
ROA -4.99%
ROE -17.59%
ROIC N/A
ROA(3y)-4.32%
ROA(5y)-11.23%
ROE(3y)-13.1%
ROE(5y)-23.87%
ROIC(3y)N/A
ROIC(5y)N/A
ETON Yearly ROA, ROE, ROICETON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • ETON has a Gross Margin of 53.46%. This is in the better half of the industry: ETON outperforms 65.63% of its industry peers.
  • In the last couple of years the Gross Margin of ETON has declined.
  • The Profit Margin and Operating Margin are not available for ETON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.43%
GM growth 5YN/A
ETON Yearly Profit, Operating, Gross MarginsETON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ETON Health Analysis

2.1 Basic Checks

  • ETON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ETON has more shares outstanding
  • Compared to 5 years ago, ETON has more shares outstanding
  • Compared to 1 year ago, ETON has an improved debt to assets ratio.
ETON Yearly Shares OutstandingETON Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ETON Yearly Total Debt VS Total AssetsETON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • ETON has an Altman-Z score of 6.03. This indicates that ETON is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 6.03, ETON is doing good in the industry, outperforming 79.69% of the companies in the same industry.
  • The Debt to FCF ratio of ETON is 3.00, which is a good value as it means it would take ETON, 3.00 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.00, ETON belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
  • ETON has a Debt/Equity ratio of 0.83. This is a neutral value indicating ETON is somewhat dependend on debt financing.
  • ETON has a worse Debt to Equity ratio (0.83) than 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 3
Altman-Z 6.03
ROIC/WACCN/A
WACC9.31%
ETON Yearly LT Debt VS Equity VS FCFETON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

2.3 Liquidity

  • ETON has a Current Ratio of 1.57. This is a normal value and indicates that ETON is financially healthy and should not expect problems in meeting its short term obligations.
  • ETON has a Current ratio of 1.57. This is in the lower half of the industry: ETON underperforms 70.83% of its industry peers.
  • A Quick Ratio of 1.17 indicates that ETON should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.17, ETON is not doing good in the industry: 74.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.17
ETON Yearly Current Assets VS Current LiabilitesETON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ETON Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 71.43% over the past year.
  • The Revenue has grown by 104.94% in the past year. This is a very strong growth!
  • The Revenue has been growing by 357.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)104.94%
Revenue growth 3Y55.53%
Revenue growth 5Y357.25%
Sales Q2Q%82.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 134.80% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ETON will show a very strong growth in Revenue. The Revenue will grow by 25.39% on average per year.
EPS Next Y2403.49%
EPS Next 2Y533.76%
EPS Next 3Y290.12%
EPS Next 5Y134.8%
Revenue Next Year39.34%
Revenue Next 2Y43.23%
Revenue Next 3Y40.91%
Revenue Next 5Y25.39%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ETON Yearly Revenue VS EstimatesETON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ETON Yearly EPS VS EstimatesETON Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ETON Valuation Analysis

4.1 Price/Earnings Ratio

  • ETON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 28.61, which means the current valuation is very expensive for ETON.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ETON indicates a somewhat cheap valuation: ETON is cheaper than 72.92% of the companies listed in the same industry.
  • ETON is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 28.61
ETON Price Earnings VS Forward Price EarningsETON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

  • ETON's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ETON is cheaper than 75.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ETON is valued a bit cheaper than the industry average as 76.04% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 69.37
EV/EBITDA 228.57
ETON Per share dataETON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ETON's earnings are expected to grow with 290.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y533.76%
EPS Next 3Y290.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ETON Dividend Analysis

5.1 Amount

  • No dividends for ETON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ETON Fundamentals: All Metrics, Ratios and Statistics

ETON PHARMACEUTICALS INC

NASDAQ:ETON (4/10/2026, 8:19:40 PM)

After market: 26.37 +0.01 (+0.04%)

26.36

-0.74 (-2.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-19
Earnings (Next)05-07
Inst Owners58.83%
Inst Owner Change0%
Ins Owners4.32%
Ins Owner Change0.12%
Market Cap719.10M
Revenue(TTM)79.95M
Net Income(TTM)-4.60M
Analysts82.22
Price Target40.12 (52.2%)
Short Float %7.4%
Short Ratio5.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-105.45%
Min EPS beat(2)-176.25%
Max EPS beat(2)-34.64%
EPS beat(4)1
Avg EPS beat(4)-87.39%
Min EPS beat(4)-176.25%
Max EPS beat(4)28.68%
EPS beat(8)3
Avg EPS beat(8)-59.71%
EPS beat(12)6
Avg EPS beat(12)-18.71%
EPS beat(16)8
Avg EPS beat(16)-22.76%
Revenue beat(2)2
Avg Revenue beat(2)4.46%
Min Revenue beat(2)1.38%
Max Revenue beat(2)7.55%
Revenue beat(4)4
Avg Revenue beat(4)7.99%
Min Revenue beat(4)1.38%
Max Revenue beat(4)11.97%
Revenue beat(8)7
Avg Revenue beat(8)5.44%
Revenue beat(12)10
Avg Revenue beat(12)11.79%
Revenue beat(16)11
Avg Revenue beat(16)3.72%
PT rev (1m)25.56%
PT rev (3m)25.56%
EPS NQ rev (1m)-45.45%
EPS NQ rev (3m)-45.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-12.16%
Revenue NY rev (1m)7.42%
Revenue NY rev (3m)7.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.61
P/S 8.84
P/FCF 69.37
P/OCF 67.18
P/B 27.03
P/tB N/A
EV/EBITDA 228.57
EPS(TTM)-0.04
EYN/A
EPS(NY)0.92
Fwd EY3.5%
FCF(TTM)0.38
FCFY1.44%
OCF(TTM)0.39
OCFY1.49%
SpS2.98
BVpS0.98
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.99%
ROE -17.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.46%
FCFM 12.75%
ROA(3y)-4.32%
ROA(5y)-11.23%
ROE(3y)-13.1%
ROE(5y)-23.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.43%
GM growth 5YN/A
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 3
Debt/EBITDA 6.8
Cap/Depr 8.23%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion 328.88%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.17
Altman-Z 6.03
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)322.69%
Cap/Depr(5y)366.88%
Cap/Sales(3y)9.51%
Cap/Sales(5y)11.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y2403.49%
EPS Next 2Y533.76%
EPS Next 3Y290.12%
EPS Next 5Y134.8%
Revenue 1Y (TTM)104.94%
Revenue growth 3Y55.53%
Revenue growth 5Y357.25%
Sales Q2Q%82.72%
Revenue Next Year39.34%
Revenue Next 2Y43.23%
Revenue Next 3Y40.91%
Revenue Next 5Y25.39%
EBIT growth 1Y61.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108955%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y212.67%
FCF growth 3Y71.23%
FCF growth 5YN/A
OCF growth 1Y986.07%
OCF growth 3Y29.73%
OCF growth 5YN/A

ETON PHARMACEUTICALS INC / ETON Fundamental Analysis FAQ

What is the fundamental rating for ETON stock?

ChartMill assigns a fundamental rating of 4 / 10 to ETON.


Can you provide the valuation status for ETON PHARMACEUTICALS INC?

ChartMill assigns a valuation rating of 4 / 10 to ETON PHARMACEUTICALS INC (ETON). This can be considered as Fairly Valued.


How profitable is ETON PHARMACEUTICALS INC (ETON) stock?

ETON PHARMACEUTICALS INC (ETON) has a profitability rating of 2 / 10.


What is the earnings growth outlook for ETON PHARMACEUTICALS INC?

The Earnings per Share (EPS) of ETON PHARMACEUTICALS INC (ETON) is expected to grow by 2403.49% in the next year.